ACE-031 for Myostatin Pathway Research

ACE-031 is a recombinant fusion protein designed to bind and inhibit myostatin, a growth differentiation factor known for its role in regulating skeletal muscle mass. By modulating myostatin activity, ACE-031 has been studied in models related to muscle wasting and muscular dystrophy.

The 1mg size is ideal for preliminary or small-scale research studies where precise dosing and controlled conditions are essential.

Why Choose ACE-031?

ACE-031 is valued for its specificity to the myostatin pathway, allowing researchers to explore the biological mechanisms behind muscle growth, regeneration, and metabolism.

Research Applications

• Myostatin inhibition studies
• Muscle mass modulation models
• Muscle atrophy prevention research
• Neuromuscular disorder investigations
• Protein signaling pathway analysis

Scientific Background

Myostatin belongs to the transforming growth factor-beta (TGF-β) superfamily. Its inhibition is linked to increased muscle mass and reduced fat accumulation in certain models. ACE-031 is engineered to act as a “decoy receptor,” binding myostatin before it interacts with muscle cell receptors.

Chemical Profile

Type: Recombinant fusion protein
Molecular Formula: N/A (protein-based)
Appearance: Lyophilized powder
Purity: ≥98% (HPLC)

Each vial contains 1mg of ACE-031, produced under strict quality guidelines for research purposes only.

Storage & Handling

Store at −20°C, protected from light and moisture. After reconstitution, refrigerate at 2–8°C and use within the suggested time frame. Avoid multiple freeze–thaw cycles.

For Research Use Only

ACE-031 1mg is intended for in vitro laboratory research only and is not for human or veterinary use.

• Myostatin – Wikipedia
• Muscular Dystrophy – Wikipedia
• TGF-β Superfamily – Wikipedia